Global Rank
#14443
Country Rank
n/a
Market Cap
455.08 M
Price
26.15
Change (%)
0.43%
Volume
485
Boiron SA's latest marketcap:
455.08 M
As of 06/06/2025, Boiron SA's market capitalization has reached $455.08 M. According to our data, Boiron SA is the 14443th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 455.08 M |
| Revenue (ttm) | 555.62 M |
| Net Income (ttm) | 12.92 M |
| Shares Out | 17.36 M |
| EPS (ttm) | 0.74 |
| Forward PE | 14.74 |
| Ex-Dividend Date | 06/03/2025 |
| Earnings Date | 07/18/2025 |
Market Cap Chart
Data Updated: 06/06/2025
Boiron SA's yearly market capitalization.
Boiron SA has seen its market value drop from €723.97 M to €399.33 M since 2020, representing a total decrease of 44.84% and an annual compound decline rate (CAGR) of 12.56%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | €399.33 M | -13.99% |
| 12/31/2024 | €465.31 M | -33.37% |
| 12/29/2023 | €698.31 M | -20.7% |
| 12/30/2022 | €880.56 M | 40.6% |
| 12/31/2021 | €626.29 M | -13.49% |
| 12/31/2020 | €723.97 M |
Company Profile
About Boiron SA
Boiron SA is a leading manufacturer and distributor of homeopathic medicines, operating in France, Europe, North America, and internationally. Founded in 1932 and headquartered in Messimy, France, the company specializes in natural healthcare solutions.
Product Offerings
Boiron provides a diverse range of homeopathic and healthcare products, including:
- Non-proprietary homeopathic medicines
- Homeopathic specialties such as Oscillococcinum, Stodal, Arnigel, and Camilia
- Other healthcare products like medical devices, dietary supplements, cosmetics, and phytotherapy
Key Homeopathic Specialties
- Oscillococcinum – For influenza symptoms (fever, chills, headaches)
- Stodal/Stodaline – Cough relief
- Arnigel – Local treatment for benign trauma
- Camilia – Teething relief for babies
- Sédatif PC – Anxiety and minor sleep disorder treatment
- Coryzalia – Cold and rhinitis symptom relief
- Homéoptic – Eye discomfort treatment
- Homéovox – Vocal disorder relief
- Homéoplasmine – Skin irritation and redness treatment
- Varésol – Chickenpox symptom relief
- Arnicare Arthritis – Benign trauma pain relief
Additional Products
- Dermoplasmine – Multi-use balm for damaged skin
- COVID self-tests & rapid antigenic tests
- LABIAMEO – Cold sore treatment
- CONVAMEO – Relief for physical and mental fatigue
Distribution Channels
Boiron products are available through:
- Pharmacies & pharmacy chains
- Wholesalers
- Grocery & drugstores
- Health food stores
- Online retail
Frequently Asked Questions
-
What is Boiron SA's (EPA-BOI) current market cap?As of 06/06/2025, Boiron SA (including the parent company, if applicable) has an estimated market capitalization of $455.08 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Boiron SA (EPA-BOI) rank globally by market cap?Boiron SA global market capitalization ranking is approximately 14443 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.